Graftys and OrthoPediatrics Partner on U.S. Distribution of Bone Cement

Graftys entered into a distribution agreement whereby OrthoPediatrics will market Graftys® QuickSet bone cement in the U.S. under the tradename QuickPack™.

QuickSet is a new generation macroporous calcium phosphate cement designed with an optimal natural cellular resorption/substitution cycle with a calcium-deficient apatite matrix that is structurally and chemically similar to native bone crystals. QuickSet employs a full range of micro- and macropores and compressive strength in the range of cancellous bone.

Graftys QuickSet/QuickPack is delivered in a closed loop double-compartment syringe specifically designed for safety, reproducibility and ease-of-use, with no risk of preparation mistake and no product loss.

Enrico Bastianelli, Chief Executive Officer of Graftys, said, “By choosing us, OrthoPediatrics offers to our products a wider and focused access to the U.S. territory. This new partnership reinforces our desire to continue to respond to the clinical issues faced daily by orthopedic surgeons.”